The stock market pummeled Cigna after the company revealed its new plan to ditch pharmacy benefit rebates will lower that ...

Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...

A Thursday Senate hearing for President Trump's surgeon general pick, Casey Means, has been postponed because she went into ...

A bidding war between Novo Nordisk and Pfizer has broken into the open for Metsera, which focuses on developing drugs to ...

A bidding war has broken into the open for the obesity-focused Metsera, with Novo Nordisk aiming to outbid Pfizer for the ...

“Into 2026, we expect only modest sequential improvement,” wrote Evercore ISI’s Elizabeth Anderson, adding: “Management ...

It’s no secret that our bodies’ ability to ward off pathogens and mount strong vaccine responses weakens with age, but ...

Join national leaders on Dec 4 to discover how Houston is accelerating life sciences growth and shaping the future of biotech ...

The Trump administration has dismantled big chunks of the federal agency focused on mental health and addiction treatment, ...

Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...

WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price ...

In September, the Food and Drug Administration released its recent complete response letter (CRL) to Lykos Therapeutics, ...